BioSpace News Archive

Career Advice

A Guide to Research and Development: Skills and Experience Needed for a Career in R&D

Find out everything you need to know about research and development, including the skills it requires and what you should do if you’re ready to make the transition into R&D.

November 14, 2022
·
3 min read
·
Christie Adams
Drug Development

MBX Biosciences Secures $115M to Advance Precision Endocrine Peptides

MBX Biosciences secured $115 million in Series B financing to advance its pipeline of Precision Endocrine Peptides for endocrine disorders.

November 14, 2022
·
3 min read
·
Alex Keown
Business

Ionis Partners with Metagenomi to Add DNA Editing to Its Toolbox

Ionis Pharmaceuticals inked a collaboration deal with Metagenomi with the goal of adding DNA editing to its RNA-targeted technologies focused on up to four genetic targets.

November 14, 2022
·
2 min read
·
Mark Terry
Pharm Country

Pittsburgh Sees Transformation into Life Sciences Hotbed

A former steel industry giant, the 21st century Pittsburgh is a global life sciences hub, transforming research, technology and startups into a thriving center for innovation.

November 14, 2022
·
5 min read
·
Lisa Munger
Drug Development

Stoke Looks to Pivotal Trial for Dravet Candidate

Stoke Therapeutics is gearing up for a pivotal trial of its lead program for a rare genetic epilepsy disease and announced positive results from its Phase I/IIa study in children with Dravet syndrome.

November 14, 2022
·
3 min read
·
Kate Goodwin
Microbial and Bacterial Cellulose Production Market Size up to 2030 - Quantitative Research by QYResearch Medical

The global Microbial and Bacterial Cellulose Production market was valued at USD 506.8 Million in 2020 and is expected to reach USD 980.9 Million by 2030, at a CAGR of 8.1%.

November 14, 2022
·
9 min read
Drug Development

Biogen-Eisai Solidly in the Lead After Roche’s Alzheimer’s Drug Misses in Phase III

Roche announced its investigational antibody gantenerumab failed to meet the primary endpoints in GRADUATE I and II - two Phase III studies in Alzheimer’s disease.

November 14, 2022
·
3 min read
·
Tristan Manalac
Business

BrainStorm Vows to Push for Adcomm Meeting on NurOwn in ALS

During its third-quarter earnings call Monday, BrainStorm Cell Therapeutics emphasized its commitment to seek an advisory committee meeting for NurOwn in ALS.

November 14, 2022
·
4 min read
·
Heather McKenzie
Deals

Indivior Bets $145M on Opiant’s Opioid Overdose Recovery Candidate

Indivior PLC announced it will acquire Opiant Pharmaceuticals and its lead candidate OPNT003, an intranasal-delivered opioid overdose recovery product.

November 14, 2022
·
3 min read
·
Alex Keown
Drug Development

Satsuma’s Headaches Mount as Migraine Candidate Flops in Phase III

Topline results from the Phase III SUMMIT trial showed Satsuma Pharmaceuticals’ migraine candidate STS101 did not meet its primary efficacy endpoint.

November 14, 2022
·
2 min read
·
Tristan Manalac